GALE closed Monday's trading at $1.41, up 17.50%. In after-hours, the stock was up 2.13% to $1.44. The partial clinical hold imposed by the FDA on Northwest Biotherapeutics' (NWBO.OB) phase III trial of DCVax-L for …
NeuVax
DALLAS, TX, Sept. 10, 2014 /CNW/ - Gale Force Petroleum Inc. (TSXV: GFP) (OTCQX: GFPMF) ("Gale Force" or the "Company") today announced that it has issued 236,114 common shares as final payment of a finder's …
I believe it is a good time to get in if it’s a stock that interests you. After the massive hit the stock took after its’ discontinuation of the NeuVax trials, it appears to have found a temporary bottom. Looking at the Open …
Wall Street analysts covering Galena Biopharma, Inc. (NASDAQ:GALE) shares are predicting that the stock
Subject to final approvals, DXC Technology intends to list on the New York Stock Exchange under the ticker …
World
Gale and Sotomayor [1985] have shown that in the Gale-Shapley ... In domains with substantial stochastic elements, such as stock picking, crowd strategies (e.g. indexing) ... Social connections often have a …
auctions
It's never a good thing when a company must resort to creative methods like a reverse stock split to stay listed on an exchange. However, Galena really didn't have a better alternative. Galena's lead candidate is GALE-401, a …
The Motley Fool
But Gale said that’s nonsense ... WHEN WASHINGTON SPEAKS GREEK, AND WALL STREET HEARS LATIN: The stock market is shrugging off some of the early controversies of the Trump administration, because …
Politico
Just go wild 😀 Bonus tip: If you want a company profile data for a particular stock (like company address, phone number, exchange codes, last year revenue) select the “Thomas Gale company profiles” instead. Please note …
You can find all of his previous articles here. And now, for some dim sum….] Greetings Irregulars, and welcome to Stock Gumshoe’s festive second BioDimSum shindig, a periodic round-up